Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Drug Discovery Today|May 2, 2015
Successful generation of structural information for fragment-based drug discoveryLinda Öster, Sofia Tapani, Yafeng Xue, et al.Expert Opinion on Drug Discovery|December 24, 2025
Protein crystallization strategies in structure-based drug designMargareta Ek, Linda Öster, Helena Käck, et al.Bioorganic & Medicinal Chemistry Letters|December 27, 2016
Discovery of triazole aminopyrazines as a highly potent and selective series of PI3Kδ inhibitorsIna Terstiege, Matthew Perry, Jens Petersen, et al.European Journal of Medicinal Chemistry|November 6, 2021
Discovery and optimization of cyclohexane-1,4-diamines as allosteric MALT1 inhibitorsStefan Schiesser, Peter Hajek, Huw E Pople, et al.Journal of Synchrotron Radiation|February 18, 2012
Solutions for the storage and handling of SPINE standard pucksCristian Bodin, Fredrik Mauritzson, Rob Horsefield, et al.The Journal of Biological Chemistry|March 20, 2024
The structures of salt-inducible kinase 3 in complex with inhibitors reveal determinants for binding and selectivityLinda Öster, Marie Castaldo, Emma de Vries, et al.Chemmedchem|February 5, 2016
Fragment Screening of Soluble Epoxide Hydrolase for Lead Generation-Structure-Based Hit Evaluation and Chemistry ExplorationYafeng Xue, Thomas Olsson, Carina A Johansson, et al.Bioorganic & Medicinal Chemistry Letters|October 16, 2014
Discovery of a novel pyrazole series of group X secreted phospholipase A2 inhibitor (sPLA2X) via fragment based virtual screeningHongming Chen, Laurent Knerr, Tomas Åkerud, et al.The Journal of Biological Chemistry|February 8, 2018
Structure and biophysical characterization of the human full-length neurturin-GFRa2 complex: A role for heparan sulfate in signalingJenny Sandmark, Göran Dahl, Linda Öster, et al.ACS Medicinal Chemistry Letters|February 19, 2021
Fragment-Based Discovery of Novel Allosteric MEK1 BindersPaolo Di Fruscia, Fredrik Edfeldt, Igor Shamovsky, et al.Pageof 2